Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 23.41 | 33.49 |
| PEG Ratio (TTM) | -1.40 | 10.21 |
| P/S Ratio (TTM) | 0.65 | 4.50 |
| P/B Ratio (TTM) | 0.53 | 6.39 |
| P/FCF Ratio (TTM) | 10.23 | 28.64 |
| Price to 5YR AVG Earnings Ratio | N/A | 46.99 |
| Price to 5YR AVG FCF Ratio | N/A | 53.68 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.07% | 8.49% |
| ROE (TTM) | 2.28% | 20.51% |
| Net Profit Margin (TTM) | 2.79% | 11.97% |
| ROIC 5YR AVG | N/A | 20.65% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -10.09% | 763.57% | N/A |
| Revenue | -3.96% | 4.21% | N/A |
| Net Income | -20.83% | 710.38% | N/A |
| Cash Flow | 127.85% | -26.81% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.94 | 1.68 |
| Quick Ratio (TTM) | 0.91 | 1.15 |
| D/E Ratio (TTM) | 0.57 | 0.69 |
| Interest Coverage (TTM) | N/A | 16.44 |
| Piotroski F-Score | 7 | 7 |
| Altman Z-Score | 1.26 | 5.34 |
| LTL to 5YR AVG FCF | N/A | 7.33 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.62% |